Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen L Rech

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Leukemia & Lymphoma|September 25, 2025
PD-L1 expression and response to immune checkpoint inhibitor therapy in malignant histiocytic neoplasmsAishwarya Ravindran, Liuyan Jiang, Gordon J Ruan, et al.
Human Pathology|October 16, 2025
Dual amyloidosis: A clinicopathologic and proteomic analysis of 111 patientsJoanna C Dalland, Surendra Dasari, Jason D Theis, et al.
American Journal of Hematology|February 27, 2024
Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosisGordon J Ruan, Saurabh Zanwar, Aishwarya Ravindran, et al.
Blood|March 31, 2026
International Expert Recommendations for the Diagnosis and Treatment of Malignant Histiocytic NeoplasmsGaurav Goyal, Oussama Abla, John K C Chan, et al.
British Journal of Haematology|November 20, 2021
Mimics of Erdheim-Chester diseaseJithma P Abeykoon, Aishwarya Ravindran, Karen L Rech, et al.
Haematologica|April 21, 2019
Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman diseaseGaurav Goyal, Aishwarya Ravindran, Jason R Young, et al.
Blood Advances|October 14, 2022
Transformation of FL into DLBCL with a PMBL gene expression signatureTristan Loveday, Gerben Duns, Lisa M Rimsza, et al.
The Oncologist|September 28, 2020
Efficacy of BRAF-Inhibitor Therapy in BRAF<sup>V600E</sup> -Mutated Adult Langerhans Cell HistiocytosisAntonious Z Hazim, Gordon J Ruan, Aishwarya Ravindran, et al.
Mayo Clinic Proceedings|September 2, 2019
The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman DiseaseGaurav Goyal, Jason R Young, Matthew J Koster, et al.
The Oncologist|May 31, 2022
Impact of a Multidisciplinary Tumor Board on the Care of Patients with Histiocytic Disorders: The Histiocytosis Working Group experienceGaurav Goyal, Jason R Young, Jithma P Abeykoon, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Leukemia & Lymphoma|September 25, 2025
PD-L1 expression and response to immune checkpoint inhibitor therapy in malignant histiocytic neoplasmsAishwarya Ravindran, Liuyan Jiang, Gordon J Ruan, et al.
Human Pathology|October 16, 2025
Dual amyloidosis: A clinicopathologic and proteomic analysis of 111 patientsJoanna C Dalland, Surendra Dasari, Jason D Theis, et al.
American Journal of Hematology|February 27, 2024
Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosisGordon J Ruan, Saurabh Zanwar, Aishwarya Ravindran, et al.
Blood|March 31, 2026
International Expert Recommendations for the Diagnosis and Treatment of Malignant Histiocytic NeoplasmsGaurav Goyal, Oussama Abla, John K C Chan, et al.
British Journal of Haematology|November 20, 2021
Mimics of Erdheim-Chester diseaseJithma P Abeykoon, Aishwarya Ravindran, Karen L Rech, et al.
Haematologica|April 21, 2019
Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman diseaseGaurav Goyal, Aishwarya Ravindran, Jason R Young, et al.
Blood Advances|October 14, 2022
Transformation of FL into DLBCL with a PMBL gene expression signatureTristan Loveday, Gerben Duns, Lisa M Rimsza, et al.
The Oncologist|September 28, 2020
Efficacy of BRAF-Inhibitor Therapy in BRAF<sup>V600E</sup> -Mutated Adult Langerhans Cell HistiocytosisAntonious Z Hazim, Gordon J Ruan, Aishwarya Ravindran, et al.
Mayo Clinic Proceedings|September 2, 2019
The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman DiseaseGaurav Goyal, Jason R Young, Matthew J Koster, et al.
The Oncologist|May 31, 2022
Impact of a Multidisciplinary Tumor Board on the Care of Patients with Histiocytic Disorders: The Histiocytosis Working Group experienceGaurav Goyal, Jason R Young, Jithma P Abeykoon, et al.
Pageof 6